Table 1.
The recombinant viruses used in this study and the related mutant amino acid sites
| Name | aa mutant sites | Name | aa mutant sites |
|---|---|---|---|
| rBB | No | rBB20s | No |
| rBB/GP2s | GP2(198G/V) | rBB20s/GP2 | GP2(198 V/G) |
| rBB/GP3s | GP3(69P/S,71 K/R,226S/P) | rBB20s/GP3 | GP3(69S/P,71R/K,226P/S) |
| rBB/GP4s | GP4(43D/N;44 F/S) | rBB20s/GP4 | GP4(43 N/D;44S/F) |
| rBB/Ms | M(70R/K) | rBB20s/M | M(70 K/R) |
| rBB/Ms-R a | No | rBB20s/M-R b | No |
a The recombinant virus rBB/Ms-R was a revertant virus from rBB/Ms and contained 70R in M. The plasmid was constructed from the full-length infectious cDNA clone pCMV-BB/Ms by using the site-directed mutagenesis described
b The recombinant virus rBB20s/M-R was a revertant virus from rBB20s/M and contained 70 K in M. The plasmid was constructed from the full-length infectious cDNA clone pCMV-BB20s/M by using the site-directed mutagenesis described